|
GANAB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.230380E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.119930E-02 |
| Normal-vs-Stage2 |
9.695800E-01 |
| Normal-vs-Stage3 |
1.113190E-01 |
| Normal-vs-Stage4 |
1.646110E-02 |
| Stage1-vs-Stage2 |
3.040400E-02 |
| Stage1-vs-Stage3 |
4.682600E-01 |
| Stage1-vs-Stage4 |
4.049800E-01 |
| Stage2-vs-Stage3 |
2.170000E-01 |
| Stage2-vs-Stage4 |
3.812400E-02 |
| Stage3-vs-Stage4 |
2.320600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.822400E-03 |
| Normal-vs-AfricanAmerican |
3.461800E-01 |
| Normal-vs-Asian |
6.099000E-01 |
| Caucasian-vs-AfricanAmerican |
1.918180E-03 |
| Caucasian-vs-Asian |
6.640600E-01 |
| AfricanAmerican-vs-Asian |
3.835200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.871790E-02 |
| Normal-vs-Female |
3.033900E-02 |
| Male-vs-Female |
9.699800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.121570E-01 |
| Normal-vs-Age(41-60Yrs) |
1.295900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.341800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.565400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.193200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.840000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.916000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.751800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.557400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.975400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.244200E-02 |
| Normal-vs-Grade 2 |
3.195700E-02 |
| Normal-vs-Grade 3 |
1.316800E-01 |
| Normal-vs-Grade 4 |
9.315100E-03 |
| Grade 1-vs-Grade 2 |
3.761000E-01 |
| Grade 1-vs-Grade 3 |
2.494600E-01 |
| Grade 1-vs-Grade 4 |
9.521400E-01 |
| Grade 2-vs-Grade 3 |
4.142400E-01 |
| Grade 2-vs-Grade 4 |
1.794160E-01 |
| Grade 3-vs-Grade 4 |
8.232000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.464300E-03 |
| Normal-vs-ccB subtype |
9.003500E-03 |
| ccA subtype-vs-ccB subtype |
7.439200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.560470E-02 |
| Normal-vs-N1 |
1.295020E-01 |
| N0-vs-N1 |
3.737600E-01 |
|
|
